comparemela.com
Home
Live Updates
Orca-Q Showcases Early Efficacy, Acceptable Safety in Haploi
Orca-Q Showcases Early Efficacy, Acceptable Safety in Haploi
Orca-Q Showcases Early Efficacy, Acceptable Safety in Haploidentical Stem Cell Transplant Without PTCy
The high-precision cellular product Orca-Q demonstrated early signals of clinical activity as well as an acceptable safety profile for patients undergoing haploidentical stem cell transplantation without posttransplant cyclophosphamide.
Related Keywords
Texas ,
United States ,
Sacramento ,
California ,
Houston ,
American ,
States Srour ,
Samera Srour ,
,
Department Of Stem Cell Transplantation ,
University Of Texas Md Anderson Cancer Center ,
Division Of Cancer Medicine ,
Stem Cell Transplantation ,
Cancer Medicine ,
Cancer Center ,
African American ,
Common Terminology Criteria ,
Adverse Events ,
Orca Bio ,
Palebresib Plus Ruxolitinib ,
Palebresib ,
Myelofibrosis ,
Jak Inhibitor Naive Myelofibrosis ,
Manifest 2 Trial ,
Cash ,
Ash Annual Meeting ,
Cpi 0610 ,